Analysis of the frequencies and of the memory T cell phenotypes of human CD8+ T cells specific for influenza A viruses

Journal of Infectious Diseases

Volumn 187, Issue 7, 2003, Pages 1075-1084

  He, Xiao Song ^a,d   Mahmood, Kutubuddin ^b   Maecker, Holden T ^c   Holmes, Tyson H ^a   Kemble, George W ^b   Arvin, Ann M ^a   Greenberg, Harry B ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDIMMUNE   (United States)

^c BD BIOSCIENCES   (United States)

^d VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; CD8 ANTIGEN; CELL MARKER;

ADULT; ANTIGEN DETECTION; ARTICLE; CELL DIFFERENTIATION; CELL SPECIFICITY; CYTOMEGALOVIRUS; EFFECTOR CELL; FLOW CYTOMETRY; GENE FREQUENCY; HUMAN; INCUBATION TIME; INFLUENZA VIRUS; INFLUENZA VIRUS A; INTERFERON PRODUCTION; LYMPHOCYTE COUNT; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMORY CELL; MONONUCLEAR CELL; NONHUMAN; PERIPHERAL CIRCULATION; PHENOTYPE; PRIORITY JOURNAL; STAINING; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE ACTIVATION; VIRUS DETECTION;

ADULT; ANTIGENS, CD27; ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOLOGIC MEMORY; INFLUENZA A VIRUS; INTERFERON TYPE II; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PHENOTYPE;

EID: 0345270018     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/368218     Document Type: Article

References (52)

1. Lamb RA, Krug RM. Orthomyxoviridae: the viruses and their replication. In: Knipe DM, Howley PM, eds. Fields virology. 4th ed. Vol 1. Philadelphia: Lippincott Williams & Wilkins, 2001:1533-79.
2. Yap KL, Ada GL, McKenzie IE Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature 1978; 273:238-9.
3. McMichael AJ, Gotch FM, Noble GR, Beare PA. Cytotoxic T-cell immunity to influenza. N Engl J Med 1983; 309:13-7.
4. Lukacher AE, Braciale VL, Braciale TJ. In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J Exp Med 1984; 160:814-26.
5. Gotch F, McMichael A, Smith G, Moss B. Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes. J Exp Med 1987; 165:408-16.
6. Kuwano K, Scott M, Young JF, Ennis FA. HA2 subunit of influenza A H1 and H2 subtype viruses induces a protective cross-reactive cytotoxic T lymphocyte response. J Immunol 1988; 140:1264-8.
7. + T-cell mechanisms in the control of respiratory virus infections. Immunol Rev 1997; 159:105-17.
8. Graham MB, Braciale TJ. Resistance to and recovery from lethal influenza virus infection in B lymphocyte-deficient mice. J Exp Med 1997; 186:2063-8.
9. Jameson J, Cruz J, Ennis FA. Human cytotoxic T-lymphocyte repertoire to influenza A viruses. J Virol 1998; 72:8682-9.
10. Cerwenka A, Morgan TM, Dutton RW. Naive, effector, and memory CD8 T cells in protection against pulmonary influenza virus infection: homing properties rather than initial frequencies are crucial. J Immunol 1999; 163:5535-43.
11. Boon AC, de Mutsert G, Graus YM, et al. Sequence variation in a newly identifed HLA-B35-restricted epitope in the influenza A virus nudeoprotein associated with escape from cytotoxic T lymphocytes. J Virol 2002; 76:2567-72.
12. Kilbourne ED. Inactivated influenza vaccines. In: Plotkin SA, Mortimer EA, eds. Vaccines. Philadelphia: WB Saunders, 1999:531-52.
13. Belshe RB, Mendelman PM, Treanor J, et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children. N Engl J Med 1998; 338:1405-12.
14. Nichol KL, Mendelman PM, Mallon KP, et al. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA 1999; 282:137-44.
15. + T cells. J Exp Med 1997; 186:1407-18.
16. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401:708-12.
17. Appay V, Nixon DF, Donahoe SM, et al. HIV-specific CDS(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med 2000; 192:63-75.
18. + T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002; 8:379-85.
19. He XS, Rehermann B, Lopez-Labrador FX, et al. Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers. Proc Natl Acad Sci USA 1999; 96:5692-7.
20. + T cell memory: relationships between epitope specificity, cell phenotype, and immediate effector function. J Immunol 2001; 167:2019-29.
21. Gamadia LE, Rentenaar RJ, Baars PA, et al. Differentiation of cytomegalovirus-specific CD8(+) T cells in healthy and immunosuppressed virus carriers. Blood 2001; 98:754-61.
22. Khan N, Shariff N, Cobbold M, et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. I Immunol 2002; 169:1984-92.
23. Couch RB, Kasel JA. Influenza. In: Lennette EH, Lennette DA, Lennette ET, eds. Diagnostic procedures for viral, rickettsial, and chlamydial infections. 7th ed. Washington, DC: American Public Health Association, 1995:431-46.
24. Lennette DA. General principles for laboratory diagnosis of viral, rickettsial, and chlamydial infections. In: Lennette EH, Lennette DA, Lennette ET, eds. Diagnostic procedures for viral, rickettsial, and chlamydial infections. 7th ed. Washington, DC: American Public Health Association, 1995:3-25.
25. Maecker HT, Dunn HS, Suni MA, et al. Use of overlapping peptide mixtures as antigens for cytokine flow cytometry. J Immunol Methods 2001; 255:27-40.
26. Vitiello A, Marchesini D, Furze J, Sherman LA, Chesnut RW. Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex. J Exp Med 1991; 173:1007-15.
27. Wills MR, Carmichael AJ, Mynard K, et al. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J Virol 1996; 70:7569-79.
28. + T cells in peripheral blood. Viral Immunol 2001; 14:59-69.
29. Roberts NJ Jr, Horan PK. Expression of viral antigens after infection of human lymphocytes, monocytes, and macrophages with influenza virus. J Infect Dis 1985; 151:308-13.
30. Ronni T, Sareneva T, Pirhonen J, Julkunen I. Activation of IFN-alpha, IFN-gamma, MxA, and IFN regulatory factor 1 genes in influenza A virus-infected human peripheral blood mononuclear cells. J Immunol 1995; 154:2764-74.
31. Bender A, Albert M, Reddy A, et al. The distinctive features of influenza virus infection of dendritic cells. Immunobiology 1998; 198:552-67.
32. Airman JD, Moss P, Goulder P, et al. Phenotypic analysis of antigen-specific T lymphocytes [published erratum appears in Science 1998; 80:1821]. Science 1996; 274:94-6.
33. Valitutti S, Muller S, Celia M, Padovan E, Lanzavecchia A. Serial triggering of many T-ceil receptors by a few peptide-MHC complexes. Nature 1995; 375:148-51.
34. Liang K, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73:13-22.
35. Fisher RA. The design of experiments. Edinburgh: Oliver & Boyd, 1935.
36. + T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency: J Clin Invest 1997; 99:1739-50.
37. Pittet MJ, Zippelius A, Speiser DE, et al. Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseases. J Immunol 2001; 166:7634-40.
38. + T cell cross-priming with exogenous antigens. J Immunol 2001; 166:7268-75.
39. Kern F, Surel IP, Faulhaber N, et al. Target structures of the CD8(+)-T-cell response to human cytomegalovirus: the 72-1dlodalton major immediate-early protein revisited. J Virol 1999; 73:8179-84.
40. Kern F, Bunde T, Faulhaber N, et al. C,vtomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals. J Infect Dis 2002; 185:1709-16.
41. Dunn HS, Haney DJ, Ghanekar SA, Stepick-Biek P, Lewis DB, Maecker HT. Dynamics of CD4 and CD8 T cell responses to cytomegalovirus in healthy human donors. J Infect Dis 2002; 186:15-22.
42. + memory T cells. J Exp Med 1997; 186: 859-65.
43. + T cells. J Immunol 2000; 165:1182-90.
44. Boon A, Fringuelli E, Graus Y, et al. Influenza A virus specific T cell immunity in humans during aging. Virology 2002; 299:100-8.
45. Sareneva T, Matikainen S, Kurimoto M, Julkunen I. Influenza A virus-induced IFN-alpha/beta and IL-18 synergistically enhance IFN-gamma gene expression in human T cells. J Immunol 1998; 160:6032-8.
46. Rammensee HG, Friede T, Stevanoviic S. MHC ligands and peptide motifs: first listing. Immunogenetics 1995; 41:178-228.
47. Rock KL, Gamble S, Rothstein L. Presentation of exogenous antigen with class I major histocompatibility complex molecules. Science 1990; 249:918-21.
48. Carbone FR, Bevan MJ. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J Exp Med 1990; 171:377-87.
49. Harding CV, Song R. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J Immunol 1994; 153:4925-33.
50. Shen Z, Reznikoff G, Dranoff G, Rock KL. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J Immunol 1997; 158:2723-30.
51. Mocarski ES Jr, Courcelle CT. Cytomegaloviruses and their replication. In: Knipe DM, Howley PM, eds. Fields virology. 4th ed. Vol 2. Philadelphia: Lippincott Williams & Wilkins, 2001:2629-73.
52. Champagne P, Ogg GS, King AS, et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 2001; 410:106-11.